Sarepta Therapeutics, Inc.
$2.27B- Market cap
- $2.38B
- Debt
- +$828.97M
- Cash
- −$939.65M
Capital structure 74% equity / 26% debt · EV / Revenue 1.03x
Quick read
Fair value engine
Each company valued on the other's multiple, then compared with the market price.
SRPT · current priceP/S 1.08x
$22.50Latest market snapshot
Implied fair value · at BE's multiple
$739.583,187.0% above market
20.81 SRPT revenue / share×35.54x BE P/S=$739.58
Market $22.50Implied $739.58
BE · current priceP/S 35.54x
$252.87Latest market snapshot
Implied fair value · at SRPT's multiple
$7.6997.0% below market
7.12 BE revenue / share×1.08x SRPT P/S=$7.69
Market $252.87Implied $7.69